Key result
The bidirectional association between cardiovascular disease and cancer, particularly the risk of cancer among heart failure patients, represents an unmet need in cardio-oncology.
Highlights the unmet need to investigate the reverse cardio-oncology relationship, specifically the risk of incident cancer among patients with heart failure.
Cancer and cardiovascular diseases (CVDs) share many of the same risk factors. 1 Some studies have shown that patients with lung and hematologic malignancies had the highest prevalence of all types of CVDs.Their prevalance is unexpectedly high and sub-optimally managed in patients with cancer.This could be an opportunity for onco-cardiologists to fulfill this unmet need and to help improve outcomes in patients with cancer and coexisting heart disease. 1 Heart failure (HF) is one of the most severe complications of many CVDs, and over the past decades we have witnessed an exponential growth in its incidence. 2ancer patients may develop HF due to the well-known cardiotoxic effects of antineoplastic treatments.In order to provide better care to subjects experiencing cardiotoxicity, cardio-oncology was born and has gained a relevant role in cardiology settings. 2Whereas HF risk from cancer drugs has been actively investigated in numerous clinical trials, there are very little data available in the setting of reverse cardio-
No takes yet. Share an insight, caveat, or question.
Júlia Toste (2024) conducted an editorial in Cardiovascular disease and cancer (Heart failure). The bidirectional association between cardiovascular disease and cancer, particularly the risk of cancer among heart failure patients, represents an unmet need in cardio-oncology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: